These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9612358)

  • 21. ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression.
    Ergul A; Walker CA; Goldberg A; Baicu SC; Hendrick JW; King MK; Spinale FG
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H2050-6. PubMed ID: 10843904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function.
    King MK; Gay DM; Pan LC; McElmurray JH; Hendrick JW; Pirie C; Morrison A; Ding C; Mukherjee R; Spinale FG
    Circulation; 2001 Jan; 103(2):308-13. PubMed ID: 11208694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure.
    Hebbar L; Dorman BH; Clair MJ; Roy RC; Spinale FG
    Anesthesiology; 1997 Mar; 86(3):649-59. PubMed ID: 9066332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of pacing site on myocardial transmural dispersion of repolarization in intact normal and dilated cardiomyopathy dogs].
    Bai R; Pu J; Liu N; Lu JG; Zhou Q; Ruan YF; Niu HY; Wang L
    Sheng Li Xue Bao; 2003 Dec; 55(6):722-30. PubMed ID: 14695492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatial disruption and enhanced degradation of collagen with the transition from compensated ventricular hypertrophy to symptomatic congestive heart failure.
    Graham HK; Trafford AW
    Am J Physiol Heart Circ Physiol; 2007 Mar; 292(3):H1364-72. PubMed ID: 17071734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.
    Seeland U; Kouchi I; Zolk O; Itter G; Linz W; Böhm M
    J Mol Cell Cardiol; 2002 Feb; 34(2):151-63. PubMed ID: 11851355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure.
    Song YH; Li BS; Chen XM; Cai H
    Int J Mol Med; 2008 Jan; 21(1):117-24. PubMed ID: 18097624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac matrix remodelling in congestive heart failure: the role of matrix metalloproteinases.
    Abou-Raya S; Naim A; Marzouk S
    Clin Invest Med; 2004 Apr; 27(2):93-100. PubMed ID: 15202828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling.
    Wei Y; Cui C; Lainscak M; Zhang X; Li J; Huang J; Zhang H; Zheng Z; Hu S
    J Cell Mol Med; 2011 Apr; 15(4):773-82. PubMed ID: 20219015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
    Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
    Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.
    Spinale FG; Coker ML; Heung LJ; Bond BR; Gunasinghe HR; Etoh T; Goldberg AT; Zellner JL; Crumbley AJ
    Circulation; 2000 Oct; 102(16):1944-9. PubMed ID: 11034943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.
    Etoh T; Joffs C; Deschamps AM; Davis J; Dowdy K; Hendrick J; Baicu S; Mukherjee R; Manhaini M; Spinale FG
    Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H987-94. PubMed ID: 11514263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure.
    Saad D; Mukherjee R; Thomas PB; Iannini JP; Basler CG; Hebbar L; O SJ; Moreland S; Webb ML; Powell JR; Spinale FG
    J Am Coll Cardiol; 1998 Nov; 32(6):1779-86. PubMed ID: 9822109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term disruption in regional left ventricular electrical conduction patterns increases interstitial matrix metalloproteinase activity.
    Mukherjee R; Zavadzkas JA; Rivers WT; McLean JE; Chang EI; Bouges S; Matthews RG; Koval CN; Stroud RE; Spinale FG
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H217-24. PubMed ID: 20472759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats.
    Iwanaga Y; Aoyama T; Kihara Y; Onozawa Y; Yoneda T; Sasayama S
    J Am Coll Cardiol; 2002 Apr; 39(8):1384-91. PubMed ID: 11955860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction.
    Vinet L; Rouet-Benzineb P; Marniquet X; Pellegrin N; Mangin L; Louedec L; Samuel JL; Mercadier JJ
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H352-60. PubMed ID: 18487442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in cultured myocardial fibroblast function following the development of left ventricular failure.
    Flack EC; Lindsey ML; Squires CE; Kaplan BS; Stroud RE; Clark LL; Escobar PG; Yarbrough WM; Spinale FG
    J Mol Cell Cardiol; 2006 Apr; 40(4):474-83. PubMed ID: 16516916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure.
    Clair MJ; King MK; Goldberg AT; Hendrick JW; Nisato R; Gay DM; Morrison AE; McElmurray JH; Krombach RS; Bond BR; Cazaubon C; Nisato D; Spinale FG
    J Pharmacol Exp Ther; 2000 Jun; 293(3):852-60. PubMed ID: 10869385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal cardiac wall motion and early matrix metalloproteinase activity.
    García RA; Brown KL; Pavelec RS; Go KV; Covell JW; Villarreal FJ
    Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1080-7. PubMed ID: 15486029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.
    Lindsey ML; Goshorn DK; Squires CE; Escobar GP; Hendrick JW; Mingoia JT; Sweterlitsch SE; Spinale FG
    Cardiovasc Res; 2005 May; 66(2):410-9. PubMed ID: 15820210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.